Crestline Management’s Structure Therapeutics GPCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-5,310
Closed -$233K 787
2024
Q3
$233K Buy
+5,310
New +$233K 0.01% 481